Viewing Study NCT01068392

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-01-24 @ 10:58 PM
Study NCT ID: NCT01068392
Status: COMPLETED
Last Update Posted: 2014-11-04
First Post: 2010-02-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)
Sponsor: Dong-A University Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsed View
None marginal zone B-cell lymphoma View
None oxaliplatin View
None prednisolone View